Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   
OVERLAP
10%

OVERLAP
BY WEIGHT
3

# OF OVERLAPPING
HOLDINGS
MEDX
27
HOLDINGS
11%
ALSO IN PSIL
PSIL
30
HOLDINGS
27%
ALSO IN MEDX
SECTOR DRIFT (MEDX minus PSIL)
OVERLAPPING HOLDINGS

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in MEDX
Weight
in PSIL
Overlap
ABBVIE INC 8.5% 3.6% 3.6%
JOHNSON & JOHNSON 5.9% 3.4% 3.4%
ALKERMES PLC 3.2% 4.7% 3.2%
MEDX Overweight Relative to PSIL
ELI LILLY & CO 16.8%
NOVARTIS AG-ADR 7.5%
ASTRAZENECA PLC 5.5%
BRISTOL-MYERS SQUIBB CO 5.0%
ABBVIE INC 4.9%
IONIS PHARMACEUTICALS, INC. 4.5%
AMGEN INC 4.4%
ALNYLAM PHARMACEUTICALS INC 3.9%
MERCK & CO. INC. 3.9%
PFIZER INC 3.5%
MEDX Underweight Relative to PSIL
ATAI LIFE SCIENCES N.V. -12.2%
RELMADA THERAPEUTICS INC -8.4%
SUPERNUS PHARMACEUTICALS INC -7.7%
NEUROCRINE BIOSCIENCES INC -4.5%
ALTO NEUROSCIENCE INC -4.4%
NEURONETICS, INC. -2.0%
ALKERMES PLC -1.4%
INCANNEX HEALTHCARE INC. -1.3%
NUMINUS WELLNESS INC -1.0%
PACIFIC BIOSCIENCES OF CALIF 0.1%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY